文献速递炎症性肠病

生物制剂时代老年克罗恩病患者回盲部切除术后结局差异

Differences in Outcomes After Ileocecal Resection in Older Adults With Crohn's Disease in the Biologic Era.
PubMed 文献 · Am J Gastroenterol · 2026-02-25

该回顾性队列研究比较了老年(≥60岁)与年轻克罗恩病患者回盲部切除术后的结局。共纳入86例老年和169例年轻患者,老年组1年(OR 0.26)和5年(OR 0.40)临床复发几率更低,但5年死亡率更高(OR 20.55)。

要点

  • 老年克罗恩病患者回盲部切除术后临床复发率低于年轻患者。
  • 老年患者术后5年死亡率显著高于年轻患者。
  • 需权衡老年患者术后复发风险与死亡风险。

核心结论

  • 老年克罗恩病患者回盲部切除术后症状相关临床复发率较低,但死亡率较高。

研究设计与样本

  • 回顾性队列研究,纳入86例老年(≥60岁)和169例年轻克罗恩病患者,均接受回盲部切除术,从病历中提取1年和5年结局。

主要发现

  • 老年组1年临床复发OR为0.26,5年临床复发OR为0.40,均低于年轻组。
  • 老年组5年死亡率OR为20.55,高于年轻组。

临床怎么用

  • 对老年克罗恩病患者行回盲部切除术决策时,应综合评估较低的复发风险与较高的死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Older adults represent a growing proportion of patients with Crohn's disease (CD). We compared outcomes after ileocecal resection between older and younger patients with CD. METHODS: We conducted a retrospective cohort study of patients who underwent ileocecal resection. Older adults were defined as those aged 60 years and older. Outcomes at one and five years were extracted from medical records. RESULTS: Among 86 older and 169 younger patients, older adults had lower odds of clinical recurrence at 1 year (OR 0.26) and 5 years (OR 0.40) but higher 5-year mortality (OR 20.55). DISCUSSION: Older adults had lower symptom-based clinical recurrence rates but higher mortality.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Harris HM, Ghoneim S, Kochar B, et al. Differences in Outcomes After Ileocecal Resection in Older Adults With Crohn's Disease in the Biologic Era. Am J Gastroenterol. 2026. PMID: 41738630. doi:10.14309/ajg.0000000000003978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。